Russia’s central bank raises key rate to 21% to rein in inflation

Russia’s central bank raises key rate to 21% to rein in inflation


09 June 2024, Russia, Moskau: A guardhouse of the Kremlin (l) and the Foreign Ministry (M, background) stand in the center of the capital. Photo: Ulf Mauder/dpa (Photo by Ulf Mauder/picture alliance via Getty Images)

Picture Alliance | Picture Alliance | Getty Images

Russia’s central bank on Friday raised its key interest rate by 200 basis points to 21%, citing higher-than-forecast consumer price increases and warning of ongoing high inflation risks in the medium term.

The institution noted annual inflation of 8.4% as of Oct. 21 and now anticipates the print will sit in a 8.0–8.5% range by the end of 2024.

“Over the medium-term horizon, the balance of inflation risks is still significantly tilted to the upside,” the bank said in a statement. “The key risks are associated with persistently high inflation expectations and the upward deviation of the Russian economy from a balanced growth path, as well as with a deterioration in foreign trade conditions.”

This breaking news story is being updated.



Source

Consumer prices rose 2.4% annually in January, less than expected
World

Consumer prices rose 2.4% annually in January, less than expected

The cost of goods and services rose at a slower annual rate than expected in January, providing hope that the nagging U.S. inflation problem could be starting to ease. The consumer price index for January accelerated 2.4% from the same time a year ago, down 0.3 percentage point from the prior month, the Bureau of […]

Read More
Dubai’s DP World replaces CEO after Epstein links emerge
World

Dubai’s DP World replaces CEO after Epstein links emerge

Sultan Ahmed Bin Sulayem of Dubai speaks at a news conference on Nov. 10, 2005 in New York City. Mario Tama | Getty Images News | Getty Images The CEO of Dubai’s largest port has been replaced by the company after details of his past relationship with the late sex offender Jeffrey Epstein were made […]

Read More
Prices, pipelines and patent cliffs: Inside pharma’s big reset
World

Prices, pipelines and patent cliffs: Inside pharma’s big reset

This earnings season, Europe’s biggest pharma companies posted results ranging from 7% beats to 3% misses — but no one really cared. Instead, drugmakers looked ahead, with 2026 shaping up to be a defining year following a dramatic 2025, and one where the impact from last year’s developments is set to crystallize. “2025 was about […]

Read More